Dexcom: Positive Catalysts Ahead To Support Growth
Willie B. Thomas/DigitalVision via Getty Images Investment action I recommended a buy rating for Dexcom (NASDAQ:DXCM) when I wrote about it during October last year, as the 3Q23 results gave me further confidence in the business's positive outlook. …